C57BL/6 Mouse Kidney Glomerular Endothelial Cells

C57BL/6 Mouse Kidney Glomerular Endothelial Cells

Cat.No.: CSC-C4286X

Species: Mouse

Source: Kidney

Cell Type: Endothelial Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C4286X
Description
C57BL/6 Mouse Kidney Glomerular Endothelial Cells from Creative Bioarray are isolated from kidney glomerular tissue of pathogen-free laboratory mice. C57BL/6 Mouse Kidney Glomerular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based coating solution for 2 min and incubated in Creative Bioarray’ Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells are detached from flasks and immediately cryo-preserved in vials. Each vial contains at least 1x10^6 cells per ml and are delivered frozen. The method we use to isolate endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic pre-coated with secondary antibody.
Species
Mouse
Source
Kidney
Recommended Medium
Complete Mouse Endothelial Cell Culture Medium
Cell Type
Endothelial Cell
Disease
Normal
Quality Control
C57BL/6 Mouse Kidney Glomerular Endothelial Cells are tested for expression of markers using antibody, VE-cadherin (CD144, VE-cadherin Antibody, C-19, sc6458, Santa Cruz); AF1002 (R&D System) or CD31/PECAM-1 (Purified Rat Anti-Mouse CD31, Catalog No. 553370, BD) by immunofluorescence staining or FACS. C57BL/6 Mouse Kidney Glomerular Endothelial Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-6 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Live cell shipment is also available on request. Never can primary cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

C57BL/6 Mouse Kidney Glomerular Endothelial Cells are specialized microvascular endothelial cells derived from renal glomeruli. In vivo, they form the blood-facing component of the glomerular filtration barrier, functioning alongside the glomerular basement membrane and podocytes. Their fenestrated architecture facilitates water and small-solute filtration, while the endothelial surface layer, including the glycocalyx, contributes to restricting plasma protein passage. These properties make glomerular endothelial cells central to investigations of renal filtration and vascular integrity.

A key research advantage is their combination of glomerular tissue origin and an established inbred genetic background. They provide a relevant cellular platform for examining glomerular endothelial mechanisms and facilitate comparisons with genetically modified mouse models.

Appropriately characterized cultures support studies of endothelial permeability, glycocalyx regulation, inflammatory activation, and responses to injury. Mouse glomerular endothelial models have demonstrated increased transendothelial albumin passage following enzymatic disruption of glycocalyx heparan sulfate. Complementary studies in C57BL/6 mice have linked endothelial surface-layer damage to increased glomerular albumin leakage, providing a mechanistic framework for connecting cellular findings with renal vascular outcomes. These applications are particularly valuable for investigating pathways relevant to proteinuria and glomerular barrier dysfunction.

These cells also support investigation of podocyte–endothelial communication, including soluble mediators that influence glycocalyx integrity and barrier function. With validated functional assays, they can help evaluate candidate interventions targeting endothelial injury or restoring barrier properties.

Panax Notoginseng Saponins Attenuate Glomerular Endothelial Glycocalyx Degradation by Inhibiting the HPSE1/EGFR/STAT3 Signaling Pathway

This study investigated whether Panax notoginseng saponins (PNS) protects against glomerular endothelial glycocalyx (eGC) injury in diabetic nephropathy (DN) by regulating the HPSE1/EGFR/STAT3 signaling axis. In vitro cell models of DN were established using mouse renal glomerular endothelial cells (MRGECs) stimulated with high glucose/high palmitic acid (HGHF). WGA staining and the expression of glycocalyx-related components, including HS, SDC-1, and EHD3 were evaluated.

HGHF stimulation reduced WGA fluorescence intensity, indicating loss of glycocalyx staining on the cell surface. Consistently, immunofluorescence and Western blot analyses showed decreased expression of HS, SDC-1, and EHD3 after HGHF exposure. HGHF also increased HPSE1 expression, suggesting enhanced glycocalyx degradation. PNS treatment suppressed HGHF-induced HPSE1 upregulation and restored the levels of HS, SDC-1, and EHD3 to varying degrees (Fig. 1A–E). These results support that PNS helps maintain endothelial glycocalyx integrity under HGHF-induced injury conditions.

PNS preserved endothelial glycocalyx integrity in HGHF-stimulated MRGECs.
Fig. 1. PNS preserved endothelial glycocalyx integrity in HGHF-stimulated MRGECs (Lei, Yue-nan, et al., 2026).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products